Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
5(63%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting4
unknown1
Active, not recruiting1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown113%
active_not_recruiting113%
recruiting450%
completed113%
terminated113%

Recent Activity

5 active trials
Showing 5 of 8
recruiting

Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI

NCT06713889
recruitingnot_applicable

Cohort of STEMI Patients 2

NCT05794022
recruiting

Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy

NCT05450783
recruitingnot_applicable

Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy

NCT06321965
terminated

PMA-FERTITHEQUE Biocollection

NCT05599724
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06713889

Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI

Recruiting
NCT05794022Not Applicable

Cohort of STEMI Patients 2

Recruiting
NCT05450783

Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy

Recruiting
NCT06321965Not Applicable

Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy

Recruiting
NCT05599724

PMA-FERTITHEQUE Biocollection

Terminated
NCT05722353Not Applicable

IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®

Active Not Recruiting
NCT05002907

Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)

Completed
NCT04591613Not Applicable

Late Clinical Events Associated With COVID-19 Infection

Unknown

All 8 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8